These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1324794)
1. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Kishimoto Y; Murakami Y; Shiraishi M; Hayashi K; Sekiya T Cancer Res; 1992 Sep; 52(17):4799-804. PubMed ID: 1324794 [TBL] [Abstract][Full Text] [Related]
2. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
3. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. Sachse R; Murakami Y; Shiraishi M; Hayashi K; Sekiya T Oncogene; 1994 Jan; 9(1):39-47. PubMed ID: 8302602 [TBL] [Abstract][Full Text] [Related]
4. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037 [TBL] [Abstract][Full Text] [Related]
5. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
6. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113 [TBL] [Abstract][Full Text] [Related]
7. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Suzuki Y; Orita M; Shiraishi M; Hayashi K; Sekiya T Oncogene; 1990 Jul; 5(7):1037-43. PubMed ID: 2197591 [TBL] [Abstract][Full Text] [Related]
8. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Murakami Y; Hayashi K; Hirohashi S; Sekiya T Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
10. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123 [TBL] [Abstract][Full Text] [Related]
11. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Suzuki H; Takahashi T; Kuroishi T; Suyama M; Ariyoshi Y; Takahashi T; Ueda R Cancer Res; 1992 Feb; 52(3):734-6. PubMed ID: 1310070 [TBL] [Abstract][Full Text] [Related]
12. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer. Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Chiba I; Takahashi T; Nau MM; D'Amico D; Curiel DT; Mitsudomi T; Buchhagen DL; Carbone D; Piantadosi S; Koga H Oncogene; 1990 Oct; 5(10):1603-10. PubMed ID: 1979160 [TBL] [Abstract][Full Text] [Related]
14. p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Marchetti A; Buttitta F; Merlo G; Diella F; Pellegrini S; Pepe S; Macchiarini P; Chella A; Angeletti CA; Callahan R Cancer Res; 1993 Jun; 53(12):2846-51. PubMed ID: 8389245 [TBL] [Abstract][Full Text] [Related]
15. p53 alterations in plutonium-induced F344 rat lung tumors. Kelly G; Stegelmeier BL; Hahn FF Radiat Res; 1995 Jun; 142(3):263-9. PubMed ID: 7761575 [TBL] [Abstract][Full Text] [Related]
16. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Mitsudomi T; Steinberg SM; Nau MM; Carbone D; D'Amico D; Bodner S; Oie HK; Linnoila RI; Mulshine JL; Minna JD Oncogene; 1992 Jan; 7(1):171-80. PubMed ID: 1311061 [TBL] [Abstract][Full Text] [Related]
17. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
18. K-ras activation in non-small cell lung cancer in the dog. Kraegel SA; Gumerlock PH; Dungworth DL; Oreffo VI; Madewell BR Cancer Res; 1992 Sep; 52(17):4724-7. PubMed ID: 1324792 [TBL] [Abstract][Full Text] [Related]
19. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer. Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215 [TBL] [Abstract][Full Text] [Related]